---
reference_id: "PMID:35110524"
title: Rare SLC13A1 variants associate with intervertebral disc disorder highlighting role of sulfate in disc pathology.
authors:
- Bjornsdottir G
- Stefansdottir L
- Thorleifsson G
- Sulem P
- Norland K
- Ferkingstad E
- Oddsson A
- Zink F
- Lund SH
- Nawaz MS
- Bragi Walters G
- Skuladottir AT
- Gudjonsson SA
- Einarsson G
- Halldorsson GH
- Bjarnadottir V
- Sveinbjornsson G
- Helgadottir A
- Styrkarsdottir U
- Gudmundsson LJ
- Pedersen OB
- Hansen TF
- Werge T
- Banasik K
- Troelsen A
- Skou ST
- Thørner LW
- Erikstrup C
- Nielsen KR
- Mikkelsen S
- DBDS Genetic Consortium
- GO Consortium
- Jonsdottir I
- Bjornsson A
- Olafsson IH
- Ulfarsson E
- Blondal J
- Vikingsson A
- Brunak S
- Ostrowski SR
- Ullum H
- Thorsteinsdottir U
- Stefansson H
- Gudbjartsson DF
- Thorgeirsson TE
- Stefansson K
journal: Nat Commun
year: '2022'
doi: 10.1038/s41467-022-28167-1
content_type: abstract_only
---

# Rare SLC13A1 variants associate with intervertebral disc disorder highlighting role of sulfate in disc pathology.
**Authors:** Bjornsdottir G, Stefansdottir L, Thorleifsson G, Sulem P, Norland K, Ferkingstad E, Oddsson A, Zink F, Lund SH, Nawaz MS, Bragi Walters G, Skuladottir AT, Gudjonsson SA, Einarsson G, Halldorsson GH, Bjarnadottir V, Sveinbjornsson G, Helgadottir A, Styrkarsdottir U, Gudmundsson LJ, Pedersen OB, Hansen TF, Werge T, Banasik K, Troelsen A, Skou ST, Thørner LW, Erikstrup C, Nielsen KR, Mikkelsen S, DBDS Genetic Consortium, GO Consortium, Jonsdottir I, Bjornsson A, Olafsson IH, Ulfarsson E, Blondal J, Vikingsson A, Brunak S, Ostrowski SR, Ullum H, Thorsteinsdottir U, Stefansson H, Gudbjartsson DF, Thorgeirsson TE, Stefansson K
**Journal:** Nat Commun (2022)
**DOI:** [10.1038/s41467-022-28167-1](https://doi.org/10.1038/s41467-022-28167-1)

## Content

1. Nat Commun. 2022 Feb 2;13(1):634. doi: 10.1038/s41467-022-28167-1.

Rare SLC13A1 variants associate with intervertebral disc disorder highlighting 
role of sulfate in disc pathology.

Bjornsdottir G(1), Stefansdottir L(2), Thorleifsson G(2), Sulem P(2), Norland 
K(2), Ferkingstad E(2), Oddsson A(2), Zink F(2), Lund SH(2), Nawaz MS(2)(3), 
Bragi Walters G(2)(3), Skuladottir AT(2), Gudjonsson SA(2), Einarsson G(2), 
Halldorsson GH(2)(4), Bjarnadottir V(5), Sveinbjornsson G(2), Helgadottir A(2), 
Styrkarsdottir U(2), Gudmundsson LJ(2), Pedersen OB(6)(7), Hansen TF(8)(9), 
Werge T(7)(10)(11), Banasik K(9), Troelsen A(7)(12), Skou ST(13)(14), Thørner 
LW(15), Erikstrup C(16), Nielsen KR(17), Mikkelsen S(16); DBDS Genetic 
Consortium; GO Consortium; Jonsdottir I(2)(3), Bjornsson A(18), Olafsson IH(18), 
Ulfarsson E(18), Blondal J(19), Vikingsson A(5), Brunak S(9), Ostrowski 
SR(7)(15), Ullum H(20), Thorsteinsdottir U(2)(3), Stefansson H(2), Gudbjartsson 
DF(2)(4), Thorgeirsson TE(21), Stefansson K(22)(23).

Collaborators: Andersen S, Brunak S, Burgdorf K, Hjalgrim H, Jemec G, Jennum P, 
Johansson PI, Nielsen KR, Nyegaard M, Bruun MT, Pedersen OB, Dinh KM, Sørensen 
E, Ostrowski S, Johansson PI, Gudbjartsson D, Stefánsson H, Þorsteinsdóttir U, 
Larsen MAH, Didriksen M, Sækmose S, Zeggini E, Hatzikotoulas K, Southam L, Gilly 
A, Barysenka A, van Meurs JBJ, Boer CG, Uitterlinden AG, Styrkársdóttir U, 
Stefánsdóttir L, Jonsson H, Ingvarsson T, Esko T, Mägi R, Teder-Laving M, 
Ikegawa S, Terao C, Takuwa H, Meulenbelt I, Coutinho de Almeida R, Kloppenburg 
M, Tuerlings M, Slagboom PE, Nelissen RRGHH, Valdes AM, Mangino M, Tsezou A, 
Zengini E, Alexiadis G, Babis GC, Cheah KSE, Wu TT, Samartzis D, Cheung JPY, 
Sham PC, Kraft P, Kang JH, Hveem K, Zwart JA, Luetge A, Skogholt AH, Johnsen MB, 
Thomas LF, Winsvold B, Gabrielsen ME, Lee MTM, Zhang Y, Lietman SA, Shivakumar 
M, Smith GD, Tobias JH, Hartley A, Gaunt TR, Zheng J, Wilkinson JM, Steinberg J, 
Morris AP.

Author information:
(1)deCODE Genetics/Amgen, Inc., Reykjavik, Iceland. gyda.bjornsdottir@decode.is.
(2)deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
(3)Faculty of Medicine, School of Health Sciences, University of Iceland, 
Reykjavik, Iceland.
(4)School of Engineering and Natural Sciences, University of Iceland, Reykjavik, 
Iceland.
(5)Landspitali University Hospital, Reykjavik, Iceland.
(6)Department of Clinical Immunology, Zealand University Hospital, Køge, 
Denmark.
(7)Department of Clinical Medicine, Faculty of Health and Medical Sciences, 
University of Copenhagen, Copenhagen, Denmark.
(8)Danish Headache Center, Dept. Neurology, Rigshospitalet-Glostrup, Glostrup, 
Denmark.
(9)Novo Nordisk Foundation Center for Protein Research, Faculty of Health and 
Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
(10)Institute of Biological Psychiatry, Mental Health Services, Copenhagen 
University Hospital, Copenhagen, Denmark.
(11)Lundbeck Foundation for GeoGenetics, GLOBE Institute, University of 
Copenhagen, Copenhagen, Denmark.
(12)Department of Orthopaedic Surgery, CAG ROAD-Research OsteoArthritis Denmark, 
Copenhagen University Hospital, Hvidovre, Denmark.
(13)Research Unit for Musculoskeletal Function and Physiotherapy, Department of 
Sports Science and Clinical Biomechanics, University of Southern Denmark, 
Odense, Denmark.
(14)The Research Unit PROgrez, Department of Physiotherapy and Occupational 
Therapy, Næstved-Slagelse-Ringsted Hospitals, Næstved, Denmark.
(15)Department of Clinical Immunology, Copenhagen University Hospital, 
Copenhagen, Denmark.
(16)Department of Clinical Immunology, Aarhus University Hospital, Aarhus, 
Denmark.
(17)Department of Clinical Immunology, Aalborg University Hospital, Aalborg, 
Denmark.
(18)Department of Neurosurgery, Landspitali University Hospital, Reykjavik, 
Iceland.
(19)Health Care Institution of West Iceland, Stykkisholmur, Iceland.
(20)Statens Serum Institut, Copenhagen, Copenhagen, Denmark.
(21)deCODE Genetics/Amgen, Inc., Reykjavik, Iceland. 
thorgeir.thorgeirsson@decode.is.
(22)deCODE Genetics/Amgen, Inc., Reykjavik, Iceland. kstefans@decode.is.
(23)Faculty of Medicine, School of Health Sciences, University of Iceland, 
Reykjavik, Iceland. kstefans@decode.is.

Erratum in
    Nat Commun. 2022 Apr 27;13(1):2419. doi: 10.1038/s41467-022-30129-6.

Back pain is a common and debilitating disorder with largely unknown underlying 
biology. Here we report a genome-wide association study of back pain using 
diagnoses assigned in clinical practice; dorsalgia (119,100 cases, 909,847 
controls) and intervertebral disc disorder (IDD) (58,854 cases, 922,958 
controls). We identify 41 variants at 33 loci. The most significant association 
(ORIDD = 0.92, P = 1.6 × 10-39; ORdorsalgia = 0.92, P = 7.2 × 10-15) is with a 
3'UTR variant (rs1871452-T) in CHST3, encoding a sulfotransferase enzyme 
expressed in intervertebral discs. The largest effects on IDD are conferred by 
rare (MAF = 0.07 - 0.32%) loss-of-function (LoF) variants in SLC13A1, encoding a 
sodium-sulfate co-transporter (LoF burden OR = 1.44, P = 3.1 × 10-11); variants 
that also associate with reduced serum sulfate. Genes implicated by this study 
are involved in cartilage and bone biology, as well as neurological and 
inflammatory processes.

© 2022. The Author(s).

DOI: 10.1038/s41467-022-28167-1
PMCID: PMC8810832
PMID: 35110524 [Indexed for MEDLINE]

Conflict of interest statement: G.B., L.S., G.T., P.S., K.N., E.F., A.O., F.Z., 
S.H.L., M.S.N., G.B.W., A.T.S., S.A.G., G.E., G.H.H., G.S., A.H., U.S., L.J.G., 
I.J., U.T., H.S., D.F.G., T.E.T., and K.S. are employees of deCODE 
Genetics/Amgen Inc. The remaining authors declare no competing interests.